[1]
“Update in Diagnosis and Management of Severe Cutaneous Adverse Reactions: Emerging Therapies and Evolving Presentations”, Can Dermatol Today, vol. 6, no. 2, pp. 23–28, Jun. 2025, doi: 10.58931/cdt.2025.62142.